{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T11:15:03Z","timestamp":1781954103788,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003321","name":"Queen's University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.hoc.2021.07.001","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T01:50:29Z","timestamp":1631670629000},"page":"1039-1049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Approach to the Patient with Bleeding"],"prefix":"10.1016","volume":"35","author":[{"given":"Megan","family":"Chaigneau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula D.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.hoc.2021.07.001_bib1","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1111\/j.1538-7836.2012.04923.x","article-title":"The evolution and value of bleeding assessment tools","volume":"10","author":"Rydz","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1","key":"10.1016\/j.hoc.2021.07.001_bib2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1538-7836.2010.04105.x","article-title":"Impact of sex, age, race, ethnicity and aspirin use on bleeding symptoms in healthy adults","volume":"9","author":"Mauer","year":"2011","journal-title":"J\u00a0Thromb Haemost"},{"issue":"12","key":"10.1016\/j.hoc.2021.07.001_bib3","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1111\/j.1538-7836.2005.01663.x","article-title":"The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study","volume":"3","author":"Rodeghiero","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"issue":"4","key":"10.1016\/j.hoc.2021.07.001_bib4","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1538-7836.2006.01847.x","article-title":"A\u00a0quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)","volume":"4","author":"Tosetto","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"issue":"12","key":"10.1016\/j.hoc.2021.07.001_bib5","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1111\/j.1538-7836.2008.03182.x","article-title":"Generation and validation of the condensed MCMDM-1VWD bleeding questionnaire for von Willebrand disease","volume":"6","author":"Bowman","year":"2008","journal-title":"J\u00a0Thromb Haemost"},{"issue":"8","key":"10.1016\/j.hoc.2021.07.001_bib6","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/j.1538-7836.2009.03499.x","article-title":"Evaluation of the diagnostic utility for von Willebrand disease of a pediatric bleeding questionnaire","volume":"7","author":"Bowman","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"issue":"9","key":"10.1016\/j.hoc.2021.07.001_bib7","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1111\/j.1538-7836.2010.03975.x","article-title":"ISTH\/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders","volume":"8","author":"Rodeghiero","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"10.1016\/j.hoc.2021.07.001_bib8","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/hae.12503","article-title":"Normal range of bleeding scores for the ISTH-BAT: adult and pediatric data from the merging project","volume":"20","author":"Elbatarny","year":"2014","journal-title":"Haemophilia."},{"issue":"1","key":"10.1016\/j.hoc.2021.07.001_bib9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"James","year":"2021","journal-title":"Blood Adv"},{"issue":"7","key":"10.1016\/j.hoc.2021.07.001_bib10","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/jth.14454","article-title":"Diagnostic utility of the ISTH bleeding assessment tool in patients with suspected platelet function disorders","volume":"17","author":"Adler","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"issue":"3","key":"10.1016\/j.hoc.2021.07.001_bib11","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/jth.14683","article-title":"Validation of the ISTH\/SSC bleeding assessment tool for inherited platelet disorders: a communication from the Platelet Physiology SSC","volume":"18","author":"Gresele","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"10.1016\/j.hoc.2021.07.001_bib12","doi-asserted-by":"crossref","first-page":"e384","DOI":"10.1111\/hae.12747","article-title":"Generation and optimization of the self-administered bleeding assessment tool and its validation as a screening test for von Willebrand disease","volume":"21","author":"Deforest","year":"2015","journal-title":"Haemophilia."},{"issue":"4","key":"10.1016\/j.hoc.2021.07.001_bib13","doi-asserted-by":"crossref","first-page":"e350","DOI":"10.1055\/s-0039-3400483","article-title":"Reliability and feasibility of the self-administered ISTH-bleeding assessment tool","volume":"3","author":"Punt","year":"2019","journal-title":"TH Open"},{"issue":"10","key":"10.1016\/j.hoc.2021.07.001_bib14","doi-asserted-by":"crossref","first-page":"e26588","DOI":"10.1002\/pbc.26588","article-title":"Generation and optimization of the self-administered pediatric bleeding questionnaire and its validation as a screening tool for von Willebrand disease","volume":"64","author":"Casey","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.hoc.2021.07.001_bib15","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1111\/hae.13271","article-title":"Let's talk period! Preliminary results of an online bleeding awareness knowledge translation project and bleeding assessment tool promoted on social media","volume":"23","author":"Reynen","year":"2017","journal-title":"Haemophilia."},{"issue":"5","key":"10.1016\/j.hoc.2021.07.001_bib16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/00365513.2016.1183260","article-title":"Use of ISTH bleeding assessment tool to predict inherited platelet dysfunction in resource constrained settings","volume":"76","author":"Rashid","year":"2016","journal-title":"Scand J Clin Lab Invest"},{"issue":"Suppl 3","key":"10.1016\/j.hoc.2021.07.001_bib17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/hae.14042","article-title":"Diagnosis of haemophilia and other inherited bleeding disorders-is a new paradigm needed?","volume":"27","author":"Srivastava","year":"2021","journal-title":"Haemophilia"},{"issue":"5","key":"10.1016\/j.hoc.2021.07.001_bib18","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/ard.32.5.413","article-title":"Articular mobility in an African population","volume":"32","author":"Beighton","year":"1973","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.hoc.2021.07.001_bib19","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/j.1365-2516.2008.01814.x","article-title":"Intracranial haemorrhage in patients with congenital haemostatic defects","volume":"14","author":"Mishra","year":"2008","journal-title":"Haemophilia"},{"issue":"5","key":"10.1016\/j.hoc.2021.07.001_bib20","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-2141.2004.05220.x","article-title":"Bleeding and bruising in patients with Ehlers\u2013Danlos syndrome and other collagen vascular disorders","volume":"127","author":"Paepe","year":"2004","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.hoc.2021.07.001_bib21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.blre.2009.06.001","article-title":"Bleeding in the heritable connective tissue disorders: mechanisms, diagnosis and treatment","volume":"23","author":"Malfait","year":"2009","journal-title":"Blood Rev"},{"issue":"2","key":"10.1016\/j.hoc.2021.07.001_bib22","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.hoc.2012.01.002","article-title":"Why is my patient bleeding or bruising?","volume":"26","author":"Rydz","year":"2012","journal-title":"Hematol Oncol Clin"},{"issue":"3","key":"10.1016\/j.hoc.2021.07.001_bib23","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3324\/haematol.10816","article-title":"High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls","volume":"92","author":"Quiroga","year":"2007","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.hoc.2021.07.001_bib24","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1538-7836.2004.00693.x","article-title":"Template bleeding time and PFA-100\u00ae have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study in 148 patients","volume":"2","author":"Quiroga","year":"2004","journal-title":"J\u00a0Thromb Haemost"},{"issue":"12","key":"10.1016\/j.hoc.2021.07.001_bib25","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1111\/j.1538-7836.2007.02752.x","article-title":"Usefulness of PFA-100\u00ae testing in the diagnostic screening of patients with suspected abnormalities of hemostasis: comparison with the bleeding time","volume":"5","author":"Podda","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"10.1016\/j.hoc.2021.07.001_bib26","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1309\/AJCP9V3RRVNZMKDS","article-title":"Development of North American consensus guidelines for medical laboratories that perform and interpret platelet function testing using light transmission aggregometry","volume":"134","author":"Hayward","year":"2010","journal-title":"Am J Clin Pathol"},{"issue":"23","key":"10.1016\/j.hoc.2021.07.001_bib27","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJM200106073442307","article-title":"The hemophilias\u2014from royal genes to gene therapy","volume":"344","author":"Mannucci","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.hoc.2021.07.001_bib28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1056\/NEJM199107183250303","article-title":"Factor XI deficiency in Ashkenazi Jews in Israel","volume":"325","author":"Asakai","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.hoc.2021.07.001_bib29","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/ajh.21405","article-title":"Clinical and laboratory diagnosis of von Willebrand disease: a synopsis of the 2008 NHLBI\/NIH guidelines","volume":"84","author":"Nichols","year":"2009","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.hoc.2021.07.001_bib30","doi-asserted-by":"crossref","first-page":"12.e1","DOI":"10.1016\/j.ajog.2009.04.024","article-title":"Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel","volume":"201","author":"James","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.hoc.2021.07.001_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2516.2000.00361.x","article-title":"Guidelines on replacement therapy for haemophilia and inherited coagulation disorders in Italy","volume":"6","author":"Bonomi","year":"2000","journal-title":"Haemophilia."},{"issue":"6","key":"10.1016\/j.hoc.2021.07.001_bib32","doi-asserted-by":"crossref","first-page":"381S","DOI":"10.1378\/chest.08-0656","article-title":"Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"133","author":"Geerts","year":"2008","journal-title":"Chest."},{"issue":"2","key":"10.1016\/j.hoc.2021.07.001_bib33","first-page":"565","article-title":"von Willebrand disease: proposing definitions for future research","volume":"5","author":"Connell","year":"2021","journal-title":"Blood Adv"},{"issue":"7","key":"10.1016\/j.hoc.2021.07.001_bib34","first-page":"3531","article-title":"Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD","volume":"111","author":"Castaman","year":"2008","journal-title":"Blood The J Am Soc Hematol"},{"key":"10.1016\/j.hoc.2021.07.001_bib35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2516.2007.01610.x","article-title":"The use of desmopressin in von Willebrand disease: the experience of the first 30 years (1977\u20132007)","volume":"14","author":"Federici","year":"2008","journal-title":"Haemophilia"},{"issue":"7","key":"10.1016\/j.hoc.2021.07.001_bib36","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/MBC.0b013e32833c2bb5","article-title":"The use of desmopressin in mild hemophilia A","volume":"21","author":"Franchini","year":"2010","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"5","key":"10.1016\/j.hoc.2021.07.001_bib37","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1365-2141.2006.06343.x","article-title":"A\u00a0review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO","volume":"135","author":"Bolton-Maggs","year":"2006","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.hoc.2021.07.001_bib38","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00277-009-0792-9","article-title":"The use of desmopressin in congenital factor XI deficiency: a systematic review","volume":"88","author":"Franchini","year":"2009","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.hoc.2021.07.001_bib39","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/bloodadvances.2020003264","article-title":"ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease","volume":"5","author":"Connell","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.hoc.2021.07.001_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14046","article-title":"WFH guidelines for the management of hemophilia","volume":"26","author":"Srivastava","year":"2020","journal-title":"Haemophilia."}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858821000800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858821000800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:17:24Z","timestamp":1760185044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858821000800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0889858821000800"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2021.07.001","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Approach to the Patient with Bleeding","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2021.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}